Member Info for JinkyJ

Great post from Brighty1 on the 06/11/2023.

More Due Diligence for you. Patent expiry dates are the big driver for M&A decisions in our sector and the very good news for Sareum shareholders is that there are some very significant and noteworthy patents due to expire within the next 2-5 years, worth billions of pounds.

• Merck MSD’s Keytruda and our combo with100% regression of tumours in lung cancer (2019) is probably the standout opportunity. With reported annual sales of over $14.38 billion the patent expiration is 2028.

• We touched on Japanese based Takeda over the weekend regarding our latest patent success and our CEO’S existing links with the company via the obesity drug Oblean® (cetilistat). Here’s a little gem for us all to digest. Entyvio’s patent expirations is just 2-3 years away in 2026. It has reported global sales of $4 Billion and the maker is, yes you’ve guessed it, Takeda.

Another company exposed to the expiry of patents – and who therefore could be an acquirer of Sareum - is Bristol Myers Squibb. They potentially could be losing exclusivity soon of Revlimid, Eliquis and Opdivo.

• Revlimid has reported global sales of $12.1 billion and its patent expiration is said to be by 2026.

• Eliquis with reported sales of over $9 billion has a patent expiration between 2027 & 2029.

• Opdivo, with reported annual sales of over $6 billion has a patent expiration dated of 2028.

Other patents expiring soon and which could prove pivotal for SDC1801/1802 and SRA737 include:

• Johnson & Johnson’s Stelara with reported annual sales of over $7 billion has a patent expiry date of between 2025 / 2026. This is very pertinent indeed to SDC1801 as it is used to treat plaque psoriasis, psoriatic arthritis and Crohn’s disease.

• Novo Nordisk’s Victoza, with reported annual sales of $3 billion. Patent expiration date imminent.

• Novartis’ Cosentyx with reported annual sales of $4 billion has a patent expiration of between 2025 / 2026.

• Amgen’s Prolia/Xgeva and its reported annual sales of $4 billion has a patent expiration of: 2025 / 2026

• Eli Lilly’s Trulicity patent expiration date is between 2027 to 2029. Trulicity has reported annual sales of $5 billion+.

• Merck’s Januvia & Janumet patent expiration date is imminent. Januvia & Janumet has reported sales of $5 billion+.

• Pfizer’s Ibrance with reported annual sales of over $5 billion has a patent expiration date of 2027

• GSK’s Dolutegravir with global annual sales of approx $6 billion has a patent expiration of between 2027 to 2029

• Regeneron /Bayer’s / Eylea has a patent expiration date of 2026. Eylea’s latest reported annual sales are $8.36 billion.

Key patent expirations: 2025 to 2026

In summary, the fact that J&J’s Stelara has annual sales of over $7 billion and targets psoriasis, psoriatic arthritis and Crohn’s disease and its patent appears be expiring in the next 2-3 y

Not so Funny Guy. Early for you, no special brew tonight, are you doing the sober October.

Black sheep

A person who causes shame or embarrassment because of deviation from the accepted standards of his or her group.

Majwand It’s abundantly clear that you are the perfect liar as you know the story here. You & we know that you are being used as a little pawn. You know the story with the Peelers and and RF. Hence the reason you are here making a complete fool of yourself.

Our day will come.

Not so Funny guy on the late night Special Brew again.

Excellent Presentation and another day closer to J&J saying yes please.

Will the fosters & special brew man make a late night appearance.

BOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO

You could be right but we could all be millionaires next week.

The sun is shining brightly.

Good luck.

Gunner go and do a cash Isa and give everyone peace man.

Maj knows the story, just silly little nonsense. He will be sacked soon.

Dumpling.

I thought you said no dumpling today as he was here earlier for a flying visit.

You are right news coming soon.

Good luck folks, our day will come.

Is Prem a holding of Maj, tells it's own story. Prem is a car crash.

Goodbye

Me thinks that J&J will be involved, of course I would say that.

Good luck everyone.

Loch Fyne, maj.

Maj, as you know, your mates at the peelers help cut up the deal with RF and are fine with the deal. You are only being used as a little pawn when you know all is fine at the peelers, nothing there you don't know. The problem you have is that it is not going you or your mates way quick enough. We know you rely on the little reward you may earn here but the record is broke. Remember all is fine at the peelers and RF as you know. A little bridge in place until the real news drops.

Last but not least we and you know that the peelers were involved in the deal. All is Fine.

Including the little liars and scoundrels that do the dirty work for the big liars and scoundrels.

The sun is shining brightly. Our day will come.

Have you been on the Fosters again funny guy, eejit.

Have a lovely day folks, onwards and upwards.

Have you been on the Fosters funny guy, eejit.

Yes, Puma did say he had closed the short.

He also told us what a great RNS APTA had on 17th August. The price on the day was 1.95. It's now down to 1.17.

So, he isn't the great Messiah he proclaims to be!